The New York City Department of Health and Mental Hygiene conducted an enhanced surveillance project to better understand the reasons patients are not treated for HCV.
The study concludes that the high burden of Hep B infection among African immigrants in the United States underscores a need for continued screening and linkage to care in this at-risk population.
The objective of this study was to assess the cost-effectiveness of (1) treating all patients with HCV vs only those with advanced fibrosis and (2) treating each stage of fibrosis.
The study suggest that PWID with higher internalized stigma are less likely to consistently use sterile syringe sources in urban settings with multiple sterile syringe access points.
Journal of General Internal Medicine, July 2015 Many of the five million Americans chronically infected with hepatitis C (HCV) are unaware of their infection and are not in care. OBJECTIVE: We implemented and evaluated HCV screening and linkage-to-care interventions in a community setting. DESIGN: We developed a comprehensive, community-based HCV screening and linkage-to-care program in … Continue reading Article | Results from a Geographically Focused, Community-Based Hep C Screening, Linkage-to-Care & Patient Navigation Program
Journal of Hepatology, August 2015 Revolutionary new drugs to cure hepatitis C virus (HCV) infection represent one of the most important breakthroughs in clinical medicine in recent decades. However, high pricing of these well-tolerated, highly efficacious all-oral regimens and high demand (actual or anticipated) has led many payers in the United States and other countries … Continue reading Article | Excluding People Who Use Drugs or Alcohol from Access to Hep C Treatment – Is This Fair, Given the Available Data?
View in PubMed | View full article in PDF In high income countries, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). In many low and middle income countries large HCV epidemics have also emerged among PWID populations. The burden of HCV-related liver disease among PWID is increasing, but … Continue reading Article | Recommendations for Management of Hep C among People Who Inject Drugs (International Journal of Drug Policy, 2015)
“Hepatitis C treatment turned me around:” Psychological and behavioral transformation related to hepatitis C treatment. Drug and Alcohol Dependence, 2015. Abstract BACKGROUND: Hepatitis C (HCV) is a significant public health problem that primarily affects current and former substance users. However, individuals with a history of substance use are less likely to have access to or … Continue reading Article | Hep C treatment turned me around: Psychological & Behavioral Transformation Related to Hep C Treatment
Journal of Sexually Transmitted Diseases, 2015 See full article: Factors Associated With HCV Infection Among HIV-Infected MSM With No Reported Injection Drug Use, NY (2000-2010) (pdf) Background: Hepatitis C (HCV) infection is a major source of morbidity and mortality among HIV-infected patients. Despite decreasing HCV incidence in the United States, the proportion of cases among men who have sex with … Continue reading Article | Factors Associated With HCV Infection Among HIV-Infected MSM With No Reported Injection Drug Use, NY (2000-2010). Journal of Sexually Transmitted Diseases, 2015
Incidence and prevalence of hepatitis c virus infection among persons who inject drugs in New York City: 2006-2013. Drug Alcohol Depend, 2015. HCV prevalence among PWID (N:1535) was 67% during the study period, and was not significantly different from that observed in 2000-2001. The estimated HCV incidence among new injectors (persons injecting for ≤6 years) … Continue reading Article | Incidence & prevalence of HCV among persons who inject drugs in NYC: 2006-2013. Drug Alcohol Depend, 2015.
Beyond Viral Response: a prospective evaluation of a community-based, multi-disciplinary, peer-driven model of HCV treatment and support. International Journal of Drug Policy, 2015. Highlights We prospectively study a community-based hepatitis C (HCV) treatment program serving active drug users in Toronto, Canada. We examine HCV care outcomes and changes in psycho-social status, including social determinants of health … Continue reading Article | A prospective evaluation of a community-based, multi-disciplinary, peer-driven model of Hep C treatment and support
An international perspective on using opioid substitution treatment (OST) to improve hepatitis C prevention and care for people who inject drugs: structural barriers and public health potential. International Journal of Drug Policy, 2015. Highlights We examined the use of mediation assisted treatment of opioid dependence to improve the HCV control. The stigmatization of drug use is … Continue reading Article | An international perspective on using opioid substitution treatment (OST) to improve hep C prevention & care for people who inject drugs
A new study demonstrates that a multi-disciplinary, community-based model of HCV treatment improves participant’s lives in ways that extend beyond Hepatitis C. Researchers from the University of Toronto worked with the Toronto Community Hep C Program to examine HCV care outcomes and changes in psycho-social-economic status, including social determinants of health and measures of well-being. … Continue reading Article | Study Shows Improved Socio-economic Outcomes After Community-based HCV Treatment Program
Between 2009 and 2013, 4811 persons 30 and younger were newly reported to the NYC Health Department with hepatitis C.
Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010. Epidemiol Infect. 2014 Nov. Bushnell G, Stennis NL, Drobnik AM, Proops DC, Ahuja SD, Bornschlegel K, Fuld J. Abstract SUMMARY Literature surrounding the burden of and factors associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in … Continue reading Article | TB & Viral Hepatitis, New York City, 2000–2010
An evaluation of duplicate Hep C antibody testing conducted by NYC Department of Health staff has been published in the latest issue of Public Health Reports, Volume 129, Number 6, November/December 2014. ABSTRACT Repeating a hepatitis C virus antibody test for a person who previously tested positive provides no new information, wastes resources, and may reflect poor … Continue reading Article | Duplicate Hep C Antibody Testing in NYC (NYC Health Dept)
Causes of Death among People with Hepatitis C in NYC, 2000‐2011. Jessie Pinchoff, PhD Candidate, MPH, Ann Drobnik, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Sarah L. Braunstein PhD, Jay K. Varma, MD. Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC DOHMH) Poster: ID Week 2013 Conference Click … Continue reading Article | Causes of Death among People with Hepatitis C in NYC, 2000‐2011
HIV/Hepatitis C (HCV) Co‐infection among Men who have Sex with Men (MSM) in New York City (NYC), 2000‐2010. Ann Drobnik, MPH, Jessie Pinchoff, PhD Candidate, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Jay K. Varma, MD, Sarah L. Braunstein, PhD. Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC … Continue reading Article | HIV/Hep C among Men who have Sex with Men in NYC, 2000‐2010 (NYC Health Dept)
See report displaying disease co-occurrence of HIV/AIDS, Hepatitis, STDs and Tuberculosis in NYC neighborhoods.